| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $19.81 ▲ +1.94% | Yesterday | $19.27 ▼ -0.82% | Tomorrow's KalVista Pharmaceuticals Inc. Common Stock (KALV) setup is anchored to $19.43 and targets $19.81 (+1.94%). The near-term read is upside; watch $20.01 / $18.85 because daily realized volatility is about 8.00%. |
Tomorrow's KalVista Pharmaceuticals Inc. Common Stock (KALV) setup is anchored to $19.43 and targets $19.81 (+1.94%). The near-term read is upside; watch $20.01 / $18.85 because daily realized volatility is about 8.00%. | ||||
| Week | $20.61 ▲ +6.05% | Last Week | $18.94 ▼ -2.54% | The 7-day KalVista Pharmaceuticals Inc. Common Stock model moves from $18.94 to $20.61 (+6.05%). It gives upside momentum context for this stock, so breaks around $20.01 / $18.85 matter more than a single tick. |
The 7-day KalVista Pharmaceuticals Inc. Common Stock model moves from $18.94 to $20.61 (+6.05%). It gives upside momentum context for this stock, so breaks around $20.01 / $18.85 matter more than a single tick. | ||||
| Month | $21.93 ▲ +12.89% | Last Month | $18.38 ▼ -5.41% | The 1-month KalVista Pharmaceuticals Inc. Common Stock target is $21.93 (+12.89%), compared with the live reference near $19.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month KalVista Pharmaceuticals Inc. Common Stock target is $21.93 (+12.89%), compared with the live reference near $19.43. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $23.92 ▲ +23.13% | Last Year | $17.54 ▼ -9.72% | The 1-year KalVista Pharmaceuticals Inc. Common Stock scenario points to $23.92 (+23.13%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year KalVista Pharmaceuticals Inc. Common Stock scenario points to $23.92 (+23.13%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $28.59 ▲ +47.14% | 5 Years Ago | $15.58 ▼ -19.80% | The 5-year KalVista Pharmaceuticals Inc. Common Stock view is $28.59 (+47.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year KalVista Pharmaceuticals Inc. Common Stock view is $28.59 (+47.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $19.43 | Mid |
| Daily Change | -6.90% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 72% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $19.43 | Daily Change | -6.90% |
| Market Cap | $982.11M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.